2-Methoxy-3-isobutyl pyrazine | CAS:24683-00-9

We serve 2-Methoxy-3-isobutyl pyrazine CAS:24683-00-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Methoxy-3-isobutyl pyrazine

Chemical Name:2-Methoxy-3-isobutyl pyrazine
CAS.NO:24683-00-9
Synonyms:2-Methoxy-3-isobutyl pyrazine
2-isobuthyl-3-methoxypyrazine
3-methoxy-2-isobutylpyrazine
2-Methoxy-3-isobutyl
2-METHOXY-3-ISOBUTYLPYRAZINE
 
Physical and Chemical Properties:
Density 1.0±0.1 g/cm3
Boiling Point 210.8±35.0 °C at 760 mmHg
Melting Point 107ºC
Molecular Formula C9H14N2O
Molecular Weight 166.220
Flash Point 80.0±0.0 °C
 
Specification:
Appearance:Colorless transparent liquid
Assay:≥99.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Flavors and fragrances intermediate



Contact us for information like 2-Methoxy-3-isobutyl pyrazine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-METHOXY-3-ISOBUTYLPYRAZINE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Methoxy-3-isobutyl Use and application,2-Methoxy-3-isobutyl pyrazine technical grade,usp/ep/jp grade.


Related News: It also said it would bar South Koreans from visiting China as tourists.4-Fluorobenzonitrile manufacturer It also said it would bar South Koreans from visiting China as tourists.5-(3-Fluorophenyl)-2-methylpyridine supplier It also said it would bar South Koreans from visiting China as tourists.4-Bromobenzotrifluoride vendor In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn.In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn.